BIT's 13th Annual World Congress of International Drug Discovery Science & Technology, Therapy and EXPO-2015
Past Conference Report

Past Conference Report

BIT's 13th Annual Congress of International Drug Discovery Science and Technology-2015 (IDDST2015), held in Double Tree by Hilton Hotel Beijing, China on October 20-22, achieved a consummation. The theme of this conference is “Innovation Driving R & D". Over 350 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Dr. Patrice P. Denefle, VP & Head of the Roche Institute, Roche SAS; Dr. Peter T. Meinke, Executive Director and External Discovery Chemistry of Merck Research Laboratories; Dr. Akiyoshi Suganuma, Group Officer of BA-CFU President, Eisai Co., Ltd.; Dr. He (Henry) Sun, President and CEO of Tasly Pharmaceuticals, Inc.; Dr. Yong Qian, President & CEO of BioMedicure LLC.…etc.

This annual congress comprised 15 Streams and 30 sessions following the ceremony, including "Pre-discovery: Understand the Diseases"; "Frontier Technology of Drug Discovery"; "Drug Discovery Driven by Chemistry"; "Biologics Drug R & D", "Biosimilar, Biobetter and Generics", "Traditional Therapies and Natural Products", "Personalized Medicine", "New Drug R & D Pipeline for Unmet Diseases"…etc.

This annual conference, brought together nearly 400 specialists from 40 countries and areas, was devoted to the leading issues and popular topics and provide up-to-date information to all over the world. On the other hand, the meeting provided a brilliant information platform for domestic researchers to communicate with international experts and pushed forward the drug discovery development. According to the investigation after the conference, most of our participants expressed that they would like to attend IDDST in the next year. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing IDDST-2016 which would be better and more successful than IDDST-2015. All of us are looking forward to meeting you again in 2016.

Conference Pictures

Opening Ceremory1

Opening Ceremory2

Mr. Weixin Wang, VP, BIT Congress Inc., China

Dr. Mingde Xia, Senior Director, Johnson & Johnson Innovation, Asia Pacific, China

Dr. Patrice P. Denefle, VP & Head of the Roche Institute, Roche SAS, France

Dr. Peter T. Meinke, Executive Director, External Discovery Chemistry, Merck Research Laboratories, China

Dr. Akiyoshi Suganuma, Group Officer, BA-CFU President, Eisai Co., Ltd., Japan

Dr. He (Henry) Sun, President and CEO, Tasly Pharmaceuticals, Inc., USA

Dr. Yong Qian, President & CEO, BioMedicure LLC., USA and China

Keynote Forum1

Keynote Forum2

Keynote Forum3

Keynote Forum4

Keynote Forum5

Keynote Forum6

Parallel Sessions1

Parallel Sessions2

Parallel Sessions3

Parallel Sessions4



Welcome Banquet1

Welcome Banquet2

Welcome Banquet3

Welcome Banquet4

Coffee Break1

Coffee Break2
Highlights of Conference

30 Chapters Covering Major Hot Fields in Drug Discovery
Special Forums on National New Drug R & D and Market Trend Covering Most Countries and Regions
300+ Drug Innovators, Elites, Key Players, Investors and Decision Makers Who Make the Drug Discovery Decade, are Reunited
Renowned Speakers of IDDST-2015
Dr. Patrice Denefle, Head, Roche, France Dr. Peter T. Meinke, Executive Director, Merck Research Laboratories, China Dr. ADr. Kiyoshi Suganuma, Group Officer, BA-CFU President, Eisai Co. Ltd., Japan Dr. Jason Wu, Executive Vice President and Chief Medical Officer
WuXiPRA Clinical Research, China
Dr Henry Sun, President and CEO, Tasly Pharmaceuticals, Inc., USA Dr. Mingde Xia, Senior Director, Johnson & Johnson Innovation Center, USA Dr. Yong Qian, President & CEO, BioMedicure LLC., USA Dr. Carsten Brockmeyer, CEO, Formycon AG, Germany
Dr. Xiang S Ye, Senior Director, Eli Lilly and Company, China Dr. Alexey Rak, Director, Sanofi R&D, France Dr. Daniel Cohen,Chairman & Chief Executive Officer, Pharnext, France Dr. Dimitrios Tzalis, Founder, Taros Chemicals GmbH Co. KG, Germany
Dr. Fritjof Linz, Vice President, Head of Biologics and Business Development, ChemPartner, China Dr. Timothy Callahan, Chief Scientific Officer, Biomedical Systems, USA Dr. Miguel Orri,Founder and Managing Director, InnovatOrri Pharma Consulting Ltd, Malaysia Dr. Charlie Xu, Vice President, Frontage Laboratories, Inc., China
Dr. Ko-Chung Lin, Founder and Chief Executive Officer, PharmaEssentia, Taiwan Dr. Racho Jordanov, President and CEO, JHL Biotech, USA Dr. John A. Moyer, Senior Director, Johnson and Johnson, USA Dr. Raymond Yang, Senior Solutions Consultant, Oracle Health Sciences Global Business Unit, China
Dr. Haiching Ma, Chief Science Officer, Reaction Biology Corporation, USA Dr. Jin Zhao, Senior Scientist, Genzyme Corporation, USA Dr. Jianfei Yang,Principal Scientist, Tempero Pharmaceuticals, USA Dr. Dan Zhang, CEO, Fountain Medical Development Ltd., China
Dr. Jun Pang, CEO, Northernchem Inc., Canada Dr. David J Madge, Project Director, WuXiAppTec., UK Dr. Herb Anthony, Associate Director, MedImmune, Inc., USA Dr. Ralf Huss, CSO, Apceth GmbH & Co. KG, Germany
Dr. Jun Xiang, Senior Director & Head, Shanghai CP Guojian Pharmaceutical Co., Ltd., China Dr. Norman Kong, VP, Shanghai Denovo Pharmatech, China Dr. Shi-Jiang (John) Lu, Senior Director of Research, Ocata Therapeutics, Inc., USA Dr. Seokjoong Kim, Research Scientist Director, ToolGen, Inc., South Korea
Dr. Carsten Hopf, Professor, Head IAB, Mannheim University of Applied Sciences, Germany Dr. Brian Dean, Professor, The Florey Insititute of Neuroscience and Mental Health, Australia Dr. Guo-Ping Zhou, Professor and Senior Principal Investigator, Gordon Life Science Institute, USA Dr. Gillet Daniel, Research Director, CEA, France
Dr. Nora Yang, Director, NIH National Center for Advancing Translational Sciences, USA Dr. Michael J.A. Walker, Professor, The University of British Columbia, Canada Dr. Chaim Putterman, Chief, Division of Rheumatology, Albert Einstein College of Medicine, USA Dr. Giulio Maria Pasinetti, Professor, Mount Sinai School of Medicine at Sinai, USA
Dr. Luana Pesco Koplowitz, President and Chief Medical & Scientific Officer, DUCK FLATS Pharma, LLC, USA Dr. Gert Fricker, Professor, University of Heidelberg, Germany Dr. Laurent Desaubry, Research Director, CNRS-University of Strasbourg, France Dr. Jan Tavernier, Professor, Ghent University, Belgium
Dr. Fengzhi Li, Chief Scientist and Lab Director, Roswell Park Cancer Institute (RPCI), USA Dr. Xiaoyan Jiang, Distinguished Scientist, BC Cancer Research Centre, USA Dr. Frank Markland, Professor, University of Southern California, USA Dr. Giovanni Dondi Dall’Orologio, Professor and Director, University of Bologna, Italy
Dr. Attilio Di Pietro, Professor and Director, CNRS University of Lyon, France Dr. Xiaojian Yao,Professor, University of Manitoba, Canada Dr. Kenneth L. Byron, Professor, Loyola University Chicago, USA Dr. Emil Alexov, Professor, Clemson University, USA
Dr. Ying Huang, Professor, State University of New York, USA Dr. Y. Lynn Wang,Professor, Weill Cornell Medical College, USA Dr. Baoxue Yang, Professor, Peking University, China Dr. Zhi-Ming Zhou, Director, Center of Pharmaceuticals, Beijing Institute of Technology, China
Dr. Si-Yun Shu, Professor, Zhujiang Hospital, Southern Medical University, China Dr. Jianhai Chen, Professor, Southern Medical University, China Dr. Xinghua Pan, Associate Research Scientist, Yale University, USA Dr. Ningli Li, Professor, Shanghai Jiao Tong University, China
Dr. Anatoly F. Vanin, Professor, Russian Academy of Sciences, Russia Dr. Concepcion Gonzalez-Bello, Full Professor, University of Santiago de Compostela, Spain Dr. Chung-Hsin Wu, Professor, National Taiwan Normal University, Taiwan Dr. Qiao Li, Associate Professor, University of Michigan, USA
Dr. Lech Kozerski, Professor, Institute of Organic Chemistry, Polish Academy of Sciences, Poland Dr. Andrew Holt, Head, ALviva Biopharmaceuticals Inc, Canada Dr. Elizabeth Scarr,Associate Professor, The University of Melbourne, Australia Dr. Rui Seabra Ferreira Junior, Director, Sao Paulo State University, Brazil
Dr. Haishan Wang, Group Leader, Institute of Molecular and Cell Biology, Singapore Dr. Henry J. Klassen, Associate Professor and Director , University of California, USA Dr. Vikrant Adsool, Scientist, Institute of Chemical and Engineering Sciences, A*STAR, Singapore Dr. Beata Skibska, Associate Professor, Medical University of Lodz, Poland
Exhibition and Poster

As part of the 2015 Drug Discovery Science and Technology Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.

Exhibitors' advantages
• The exhibition will be visited by participants of the conference who are your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.

Exhibition Date:
Set-up date: October 27, 2015
Show dates: October 28-30, 2015 09:00-18:00
Place: Beijing, China

Previous Event Report

BIT's 12th Annual Congress of International Drug Discovery Science and Technology-2014 (IDDST2014), held in Tongli Lakeview Hotel, Suzhou, China on November 18-20, achieved a consummation. The theme of this conference is “Shaping the Bright Future of Drug Discovery". Over 300 honored guests presented at the ceremony and gave brilliant speeches on invitation…                                                  More

News Release
Thank BioMedicure for the generous sponsorship to Keynote Forum of IDDST-2015!
Full Program will be closed on Sep., book your speech slot right now!
Great Opportunity for Exhibitors, Sponsors and Advertisers Worldwide!
Hosting Organization

Information Research Center of International Talent, SAFEA

Operating Organization

BIT Group Global Ltd.
Foreign Experts Databank of SAFEA-Dalian Branch

Official Travel Agency

BIT World Travel Service, Inc.



Media Partners
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Group Global Ltd.